238 related articles for article (PubMed ID: 32845521)
21. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
Gao J; Hu S
Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
[TBL] [Abstract][Full Text] [Related]
22. BET 1: Lopinavir-ritonavir and COVID-19.
Dolan D; Ingham J; Baombe J
Emerg Med J; 2020 Jul; 37(7):450-451. PubMed ID: 32616658
[No Abstract] [Full Text] [Related]
23. Existing Drugs Might Treat COVID-19.
Abbasi J
JAMA; 2020 Jun; 323(22):2239. PubMed ID: 32515802
[No Abstract] [Full Text] [Related]
24. [Not Available].
Nau JY
Rev Med Suisse; 2020 Mar; 16(687):606-607. PubMed ID: 32216186
[No Abstract] [Full Text] [Related]
25. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19.
D'Acquarica I; Agranat I
Drug Discov Today; 2020 Jul; 25(7):1121-1123. PubMed ID: 32371138
[No Abstract] [Full Text] [Related]
26. COVID-19 pandemic: what can pharmaceutical formulation and drug delivery experts offer?
Alany RG
Pharm Dev Technol; 2020 Jul; 25(6):649. PubMed ID: 32423342
[No Abstract] [Full Text] [Related]
27. Drug researchers pursue new lines of attack against COVID-19.
Harrison C
Nat Biotechnol; 2020 Jun; 38(6):659-662. PubMed ID: 32417850
[No Abstract] [Full Text] [Related]
28. Repurposing antimalarials and other drugs for COVID-19.
Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
[No Abstract] [Full Text] [Related]
29. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
Nisole S; Saulnier A; Gatignol A
Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
[No Abstract] [Full Text] [Related]
30. Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID-19.
Hartman D; Kern S; Brown F; Minton SK; Rayner CR
Clin Transl Sci; 2020 Jul; 13(4):646-648. PubMed ID: 32441462
[TBL] [Abstract][Full Text] [Related]
31. Audio Interview: Operation Warp Speed and Covid-19 Therapeutics.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Sep; 383(12):e92. PubMed ID: 32937059
[No Abstract] [Full Text] [Related]
32. Does hydroxychloroquine combat COVID-19? A timeline of evidence.
Alia E; Grant-Kels JM
J Am Acad Dermatol; 2020 Jul; 83(1):e33-e34. PubMed ID: 32283236
[No Abstract] [Full Text] [Related]
33. Current Perspective of Antiviral Strategies against COVID-19.
Ahidjo BA; Loe MWC; Ng YL; Mok CK; Chu JJH
ACS Infect Dis; 2020 Jul; 6(7):1624-1634. PubMed ID: 32485102
[TBL] [Abstract][Full Text] [Related]
34. Sofosbuvir for COVID-19 infection: A potential candidate.
Gupta R; Dhamija P
Indian J Pharmacol; 2020; 52(3):232-233. PubMed ID: 32874010
[No Abstract] [Full Text] [Related]
35. Pharmacologic Therapy for COVID-19 Infection.
Nusbaum N
J Community Health; 2020 Jun; 45(3):435-436. PubMed ID: 32314081
[TBL] [Abstract][Full Text] [Related]
36. Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy.
Saini KS; Lanza C; Romano M; de Azambuja E; Cortes J; de Las Heras B; de Castro J; Lamba Saini M; Loibl S; Curigliano G; Twelves C; Leone M; Patnaik MM
Br J Cancer; 2020 Sep; 123(5):694-697. PubMed ID: 32572174
[TBL] [Abstract][Full Text] [Related]
37. Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning.
Ackerman EE; Shoemaker JE
Viruses; 2020 Sep; 12(10):. PubMed ID: 32993136
[TBL] [Abstract][Full Text] [Related]
38. No Easy Answers in Allocating Unapproved COVID-19 Drugs Outside Clinical Trials.
Webb J; Shah L; Lynch HF
Am J Bioeth; 2020 Sep; 20(9):W1-W4. PubMed ID: 32840448
[No Abstract] [Full Text] [Related]
39. The coronavirus outbreak could make it quicker and easier to trial drugs.
Ledford H
Nature; 2020 Jun; 582(7811):172. PubMed ID: 32504019
[No Abstract] [Full Text] [Related]
40. The database-based strategy may overstate the potential effects of traditional Chinese medicine against COVID-19.
Huang YX; Wang WX; Zhang S; Tang YP; Yue SJ
Pharmacol Res; 2020 Sep; 159():105046. PubMed ID: 32590099
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
